Huang, W., Zhou, J., Li, J., Wan, Y., Hu, C., Liu, M., . . . Gong, L. PD-L1/TLR7 dual-targeting nanobody-drug conjugate mediates potent tumor regression via elevating tumor immunogenicity in a host-expressed PD-L1 bias-dependent way. BMJ Publishing Group.
Chicago Style (17th ed.) CitationHuang, Wei, et al. PD-L1/TLR7 Dual-targeting Nanobody-drug Conjugate Mediates Potent Tumor Regression via Elevating Tumor Immunogenicity in a Host-expressed PD-L1 Bias-dependent Way. BMJ Publishing Group.
MLA (9th ed.) CitationHuang, Wei, et al. PD-L1/TLR7 Dual-targeting Nanobody-drug Conjugate Mediates Potent Tumor Regression via Elevating Tumor Immunogenicity in a Host-expressed PD-L1 Bias-dependent Way. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.